Spruce Biosciences Appoints Interim Chief Medical Officer

TipRanksDec 28, 2024 06:49

H.C. Wainwright Maintains Spruce Biosciences(SPRB.US) With Hold Rating

Futu NewsDec 16, 2024 20:31 · Ratings

Hold Rating for Spruce Biosciences Amid Clinical Setbacks and Strategic Uncertainties

TipRanksDec 16, 2024 19:38

Spruce Biosciences (SPRB) Upgraded to Buy: Here's Why

Zacks Dec 14, 2024 00:15

Guggenheim Reiterates Neutral on Spruce Biosciencesto Neutral

BenzingaDec 12, 2024 23:38

RBC Capital Maintains Spruce Biosciences(SPRB.US) With Hold Rating, Cuts Target Price to $1.5

Futu NewsDec 11, 2024 21:33 · Ratings